Home Multimedia Podcasts Drug Repositioning as a Viable Business Model Drug Repositioning as a Viable Business Model March 10, 2011 Aris Persidis, Ph.D., President, Biovista /wp-content/uploads/2018/09/gencast_030911.mp3 PodcastsResourcesBusiness ethicDrugsEthicsEthics, law and policyPharmacology
